Bahrain - English - الهيئة الوطنية لتنظيم المهن والخدمات الصحية، مملكة البحرين

bahrain pharmacy - insulin glargine - solution for injection - 100

Philippines - English - FDA (Food And Drug Administration)

sanofi-aventis philippines, inc.; distributor: sanofi-aventis philippines, inc. - insulin glulisine - solution for injection (sc) - 3.49 mg/ml (equivalent to 100 units/ml)

European Union - English - EMA (European Medicines Agency)

sanofi-aventis deutschland gmbh - insulin glulisine - diabetes mellitus - drugs used in diabetes - treatment of adults, adolescents and children, six years or older with diabetes mellitus, where treatment with insulin is required.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis, germany - insulin glulisine - solution for injection - 100 u/ml

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

sanofi-aventis, germany - insulin glulisine - solution for injection - 100 u/ml

Canada - English - Health Canada

sanofi-aventis canada inc - insulin glulisine (recombinant dna origin) - solution - 100unit - insulin glulisine (recombinant dna origin) 100unit - insulins

Canada - English - Health Canada

sanofi-aventis canada inc - insulin glulisine (recombinant dna origin) - solution - 100unit - insulin glulisine (recombinant dna origin) 100unit - insulins

Canada - English - Health Canada

sanofi-aventis canada inc - insulin glulisine (recombinant dna origin) - solution - 100unit - insulin glulisine (recombinant dna origin) 100unit - insulins

Canada - English - Health Canada

sanofi-aventis canada inc - insulin glulisine (recombinant dna origin) - solution - 100unit - insulin glulisine (recombinant dna origin) 100unit - insulins

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - insulin glulisine -